News
Newk's Raises more than $110,000 for OCRFA
When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis…
Zubik v. Burwell & the Supreme Court
FOR IMMEDIATE RELEASE May 17, 2016 Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v…
Webinar: Clinical Trials: What you need to know
Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer…
Long Term Survival Study Recruiting Participants
The Consortium for Long-Term Survival — is bringing together research groups worldwide…
OCRFA Research Helps Explain Resistance to Chemotherapy
(May 4, 2016) Research funded in part by an OCRFA research grant to Dr…
OVARYact
Lauren Richards lost her mom Rochelle Richards to ovarian cancer earlier this year. Lauren set out on a mission to make a difference in her community and to honor her mom’s journey…
The Vicki Welsh Fund
The Vicki Welsh Fund for Ovarian Cancer began 10 years ago, with the goal of fighting ovarian cancer through awareness, education, research, and support…
Irregular Periods May Increase Ovarian Cancer Risk
Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…
Irregular Periods May Increase Ovarian Cancer Risk
(May 2, 2016) Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards
May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-‐affiliated scientists…
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A…
Hormone Therapy Safe After Nonserous Ovarian Cancer
(April 25, 2016) New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer…